GDF11, a target of miR-32-5p, suppresses high-glucose-induced mitochondrial dysfunction and apoptosis in HK-2 cells through PI3K/AKT signaling activation

Int Urol Nephrol. 2023 Jul;55(7):1767-1778. doi: 10.1007/s11255-023-03495-3. Epub 2023 Feb 7.

Abstract

Purpose: To investigate the role and underlying mechanism of GDF11 on diabetic nephropathy (DN)-related mitochondrial dysfunction and apoptosis.

Methods: A DN model of rats was established in this study. Human Kidney-2 (HK-2) cells were cultured under high-glucose (HG) condition with or without recombinant GDF11 (rGDF11). Mitochondrial morphology of HK-2 cells was analyzed by transmission electron microscope and MitoTracker Red CMXRos staining. Mitochondrial membrane potential (MMP) and ROS production were monitored using JC-1 assay kit and MitoSOX staining, respectively. Cell apoptosis was detected by TUNEL or flow cytometry assays.

Results: Herein, we observed that GDF11 was down-regulated in renal cortex and serum of DN rats, which was accompanied by renal mitochondrial morphological abnormalities. In line with the findings in vivo, HK-2 cells exposed to HG presented with mitochondrial morphological alterations and further apoptosis accompanied by GDF11 reduction. In addition, HG promoted a decrease in MMP while an increase in mitochondrial ROS production. Conversely, rGDF11 treatment significantly alleviated these HG-induced mitochondrial defects in HK-2 cells. Meanwhile, HK-2 cell apoptosis induced by HG was simultaneously suppressed by rGDF11. Mechanistically, the decreased levels of p-AKT induced by HG were attenuated after rGDF11 administration. Inhibition of the PI3K/AKT pathway resisted the effects of rGDF11 on the MMP and apoptosis of HK-2 cells. In addition, we identified that GDF11 is a target of miR-32-5p. Up-regulation of miR-32-5p could inhibit the expression of GDF11.

Conclusion: rGDF11 treatment rescued HG-induced HK-2 cell mitochondrial dysfunction and apoptosis, which may be dependent on the activation of the PI3K/AKT pathway.

Keywords: Apoptosis; Diabetic nephropathy; GDF11; Mitochondrial dysfunction; PI3K/AKT pathway.

MeSH terms

  • Animals
  • Apoptosis
  • Bone Morphogenetic Proteins / metabolism
  • Diabetic Nephropathies* / metabolism
  • Glucose / metabolism
  • Glucose / pharmacology
  • Growth Differentiation Factors / metabolism
  • Growth Differentiation Factors / pharmacology
  • Humans
  • Kidney / abnormalities
  • Kidney / metabolism
  • MicroRNAs* / metabolism
  • Mitochondria / metabolism
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Reactive Oxygen Species / metabolism
  • Urogenital Abnormalities

Substances

  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • Reactive Oxygen Species
  • Glucose
  • MicroRNAs
  • GDF11 protein, human
  • Bone Morphogenetic Proteins
  • Growth Differentiation Factors
  • MIRN32 microRNA, human

Supplementary concepts

  • Renal Adysplasia